Nicolas Langlitz, Neuropsychedelia. The revival of hallucinogen research since the Decade of the brain

Aronov, Milana

doi:10.3917/rac.034.0093

Cited by 5 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The influence of dispositifs is particularly clear in studies of innovative trial designs in the field of "psychedelic" psychiatry. Clinical trials designed to study the effects of psychotropic substances such as MDMA (3,4-methylenedioxy-methamphetamine) and LSD (lysergic acid diethylamide) acknowledge the profound influence of the setting on effects, including the pivotal role of the therapist who administers the drug (Dyke 2008;Langlitz 2012Langlitz , 2016Winkelman & Roberts 2007). Oram (2014) describes the experiment of the Spring Grove Group, in which LSD was used to help alcoholic patients overcome their addictions.…”

Section: Making Pharmaceuticals Work In Clinical Experimentsmentioning

confidence: 99%

Fluid Drugs: Revisiting the Anthropology of Pharmaceuticals

Hardon

Sanabria²

2017

Annu. Rev. Anthropol.

125

View full text Add to dashboard Cite

show abstract

Section: Making Pharmaceuticals Work In Clinical Experimentsmentioning

confidence: 99%

Fluid Drugs: Revisiting the Anthropology of Pharmaceuticals

Hardon

Sanabria²

2017

Annu. Rev. Anthropol.

125

View full text Add to dashboard Cite

show abstract

“…Although it is an important issue, it still keeps a question mark in minds with a limited number of samples and limited number of studies that psychedelics can cause psychosis-like pictures in people who do not have psychiatric complaints before (Dos Santos et al, 2017). There are many definitions such as Psychotomimetics, psychotogens, hallucinogens and psychodysleptics have been used as a result of these experiences from past to present, in the last instance it has been termed psychedelics (mind-manifesting) by the British scientists Humphrey Osmond and John Smythies (Carhart-Harris et al, 2013;Hartogsohn, 2017Hartogsohn, , 2020Johansen & Krebs, 2015;Langlitz, 2013).…”

Section: Ethical Concernsmentioning

confidence: 99%

Psychedelic therapy in depression and substance use disorders

Korkmaz,

Cikrikcili,

Akan

et al. 2024

Eur J of Neuroscience

View full text Add to dashboard Cite

Psychoactive substances obtained from botanicals have been applied for a wide variety of purposes in the rituals of different cultures for thousands of years. Classical psychedelics from N,N′‐dimethyltryptamine, psilocybin, mescaline and various lysergamides cause specific alterations in perception, emotion and cognition by acting through serotonin 5‐HT2A receptor activation. Lysergic acid diethylamide, the first famous breakthrough in the field, was discovered by chance by Albert Hoffman in the Zurich Sandoz laboratory in 1943, and studies on its psychoactive effects began to take place in the literature. Studies in this area were blocked after the legislation controlling the use and research of psychedelic drugs came into force in 1967, but since the 1990s, it has started to be a matter of scientific curiosity again by various research groups. In particular, with the crucial reports of psychotherapy‐assisted psilocybin applications for life‐threatening cancer‐related anxiety and depression, a new avenues have been opened in the treatment of psychiatric diseases such as treatment‐resistant depression and substance addictions. An increasing number of studies show that psychedelics have a very promising potential in the treatment of neuropsychiatric diseases where the desired efficiency cannot be achieved with conventional treatment methods. In this context, we discuss psychedelic therapy, encompassing its historical development, therapeutic applications and potential treatment effects—especially in depression, trauma disorders and substance use disorders—within the framework of ethical considerations.

show abstract

“…There has been little acknowledgement of the hegemony of western science over other forms of knowledge-building, and the 'indigenous shamanisms and accompanying ontologies and epistemologies' (Fotiou, 2020, p. 16) from which this knowledge has been appropriated. The revival of psychedelic science since the 1990s has even been said to be 'defined by a decisive break with the vision of a counterculture' (Langlitz, 2012). In the wake of a long chill around psychedelic research, the need to reiterate the scientific legitimacy of the methods being used to once again test their use appears to have required researchers to describe this next phase of research as 'decidedly psychedelic science' (Richert & Dyck, 2020).…”

Section: Psychedelics and The Political: A Partial Historymentioning

confidence: 99%

Acid feminism: Gender, psychonautics and the politics of consciousness

Dymock

2023

The Sociological Review

View full text Add to dashboard Cite

Psychedelic substances have undergone a transformation in the public consciousness over the last 15 years. However, the most influential first-person narratives of psychonauts and ‘scientist-shamans’ navigating the frontiers of consciousness have tended to entirely exclude women’s experiences and voices. Psychedelic feminism, has emerged to signify the role consciousness expansion and experimentation might play in rejuvenating feminism’s collective imagination, and undoing the historical silencing of women’s voices in psychedelic culture and research. Drawing on Mark Fisher’s work on acid communism, the feminist psychedelic humanities, narcofeminism and autobiographical life-writing by women on experimental psychedelic substance use, this article investigates the promise of acid feminism for the wider narcofeminist movement, and its implications for undoing some key precepts endemic in psychedelic culture and research.

show abstract

Nicolas Langlitz, Neuropsychedelia. The revival of hallucinogen research since the Decade of the brain

Cited by 5 publications

References 0 publications

Fluid Drugs: Revisiting the Anthropology of Pharmaceuticals

Fluid Drugs: Revisiting the Anthropology of Pharmaceuticals

Psychedelic therapy in depression and substance use disorders

Acid feminism: Gender, psychonautics and the politics of consciousness

Contact Info

Product

Resources

About